The value of cysteinyldopa in the follow-up of disseminated malignant melanoma

In a series of 92 patients with malignant melanoma, clinical stage III or IV, both 5-S-cysteinyldopa (5SCD) and 6-hydroxy-5-methoxyindole-2-carboxylic acid (6H5MI2C) were measured in urine during chemotherapy. A total of 434 urine specimens were analysed. The sensitivity of 5SCD for the detection of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Melanoma research 2000-08, Vol.10 (4), p.363-369
Hauptverfasser:	Kärnell, R, Kågedal, B, Lindholm, C, Nilsson, B, Arstrand, K, Ringborg, U
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers, Tumor - urine Cysteinyldopa - urine Disease Progression Female Follow-Up Studies Humans Indoles - urine Male MEDICIN Medicin och hälsovetenskap MEDICINE Melanoma - drug therapy Melanoma - secondary Melanoma - urine Middle Aged Skin Neoplasms - drug therapy Skin Neoplasms - pathology Skin Neoplasms - urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!